Chemours (CC) Current Deferred Revenue (2015 - 2021)

Chemours has reported Current Deferred Revenue for 7 years, with the latest figure at $3.0 million in Q4 2021.

• For the quarter ending Q4 2021, Current Deferred Revenue fell 57.14% year-over-year to $3.0 million; the trailing twelve-month figure through Dec 2021 stood at $3.0 million (down 57.14% YoY), and the FY2021 full-year result was $3.0 million, down 57.14% from the prior year.
• Current Deferred Revenue for Q4 2021 stood at $3.0 million, up from $2.0 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $23.0 million in Q1 2017, with the low at $2.0 million in Q3 2021.
• Average Current Deferred Revenue over 5 years is $7.3 million, with a median of $7.0 million recorded in 2019.
• Year-over-year, Current Deferred Revenue slumped 89.47% in 2017 and jumped 60.0% in 2019.
• Tracing CC's Current Deferred Revenue over 5 years: stood at $8.0 million in 2017, then slipped by 25.0% to $6.0 million in 2018, then advanced by 16.67% to $7.0 million in 2019, then changed by 0.0% to $7.0 million in 2020, then sank by 57.14% to $3.0 million in 2021.
• The last three Current Deferred Revenue figures came in at $3.0 million (Q4 2021), $2.0 million (Q3 2021), and $3.0 million (Q2 2021), per Business Quant data.

Peer Comparison